ATE123941T1 - Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung. - Google Patents

Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung.

Info

Publication number
ATE123941T1
ATE123941T1 AT91117799T AT91117799T ATE123941T1 AT E123941 T1 ATE123941 T1 AT E123941T1 AT 91117799 T AT91117799 T AT 91117799T AT 91117799 T AT91117799 T AT 91117799T AT E123941 T1 ATE123941 T1 AT E123941T1
Authority
AT
Austria
Prior art keywords
amino acids
protection
heart tissue
ischemic heart
restoration
Prior art date
Application number
AT91117799T
Other languages
German (de)
English (en)
Inventor
David Madsen
Gary Pace
Bruce Rowe
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24423981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE123941(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of ATE123941T1 publication Critical patent/ATE123941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91117799T 1990-10-30 1991-10-18 Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung. ATE123941T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60551490A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
ATE123941T1 true ATE123941T1 (de) 1995-07-15

Family

ID=24423981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91117799T ATE123941T1 (de) 1990-10-30 1991-10-18 Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung.

Country Status (9)

Country Link
EP (1) EP0483614B1 (ja)
JP (1) JPH04264024A (ja)
AT (1) ATE123941T1 (ja)
AU (1) AU655780B2 (ja)
CA (1) CA2054134A1 (ja)
DE (1) DE69110615T2 (ja)
DK (1) DK0483614T3 (ja)
ES (1) ES2074623T3 (ja)
GR (1) GR3017321T3 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
DE69637676D1 (de) * 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1320782B1 (it) 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
JPWO2002030418A1 (ja) * 2000-10-13 2004-02-19 中外製薬株式会社 脂質代謝改善用組成物
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
JP2018522950A (ja) * 2015-08-11 2018-08-16 杉山　理 血液循環の改善及びミトコンドリアエネルギー産生の維持のためのシステム並びに方法
JP6838752B2 (ja) * 2019-08-30 2021-03-03 株式会社東洋新薬 血流改善組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228127A1 (de) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Aminosaeuren-infusionsloesungen
WO1988001872A1 (en) * 1986-09-10 1988-03-24 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis

Also Published As

Publication number Publication date
EP0483614B1 (en) 1995-06-21
AU8567091A (en) 1992-05-07
GR3017321T3 (en) 1995-12-31
DE69110615T2 (de) 1995-12-14
AU655780B2 (en) 1995-01-12
CA2054134A1 (en) 1992-05-01
ES2074623T3 (es) 1995-09-16
JPH04264024A (ja) 1992-09-18
DK0483614T3 (da) 1995-10-30
EP0483614A1 (en) 1992-05-06
DE69110615D1 (de) 1995-07-27

Similar Documents

Publication Publication Date Title
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
ES2043890T3 (es) Nuevo uso medico.
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
DE3752045D1 (de) Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
EP0336880A3 (de) Verwendung von topisch applizierbaren Präparaten zur Behandlung der Altershaut
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IE791235L (en) Acyl-derivatives of carnitine.
ATE123941T1 (de) Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung.
ATE220923T1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE3689585D1 (de) Peptide mit Ester-Sulfat-Gruppen.
EP0199117A3 (en) New therapeutical use of phosphocreatine
ZA87466B (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
DE69725312D1 (de) Verbesserte elektrophoretische verabreichung von therapeutischen wirkstoffen mit polybasischen anionischen gegenionen
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
EP0324348A3 (de) Piperidincarboxamid-Derivate zur Behandlung von Bradycardien und Bradyarrhythmien
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
ES8609210A1 (es) Un procedimiento para preparar una sal de 1-(2-alilfenoxi)-3-isopropilamino-amino-2-propanol
ITMI922534A1 (it) Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked